Replica Analytics develops technology to generate privacy-protected synthetic data that maintains the statistical properties of real data without breaching regulatory privacy requirements. Its flagship product, Replica Synthesis, provides synthetic real-world data and synthetic clinical trial data to data scientists and researchers. The company is led by co-founder and director Khaled El Emam and is based in Ottawa, ON, Canada. Replica Analytics raised new pre-seed funding to accelerate research and further develop its data synthesis and data simulation technologies. The financing supports continued product and research efforts around privacy-preserving synthetic data generation.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Sep 2020